C. R. Rizza

6.2k total citations · 1 hit paper
92 papers, 4.8k citations indexed

About

C. R. Rizza is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, C. R. Rizza has authored 92 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Hematology, 12 papers in Molecular Biology and 11 papers in Genetics. Recurrent topics in C. R. Rizza's work include Hemophilia Treatment and Research (59 papers), Blood Coagulation and Thrombosis Mechanisms (23 papers) and Platelet Disorders and Treatments (16 papers). C. R. Rizza is often cited by papers focused on Hemophilia Treatment and Research (59 papers), Blood Coagulation and Thrombosis Mechanisms (23 papers) and Platelet Disorders and Treatments (16 papers). C. R. Rizza collaborates with scholars based in United Kingdom, United States and Canada. C. R. Rizza's co-authors include Rosemary J. D. Spooner, Douglas F. Nixon, Andrew J. McMichael, John Elvin, Rosemary Biggs, F. Giannelli, Paul Giangrande, Jonathan Rothbard, Frances Gotch and Charles R. M. Bangham and has published in prestigious journals such as Nature, The Lancet and Nucleic Acids Research.

In The Last Decade

C. R. Rizza

90 papers receiving 4.4k citations

Hit Papers

Human immunodeficiency virus genetic variation that can e... 1991 2026 2002 2014 1991 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. R. Rizza United Kingdom 34 2.1k 1.2k 974 888 869 92 4.8k
Edward D. Gomperts United States 32 1.8k 0.8× 1.9k 1.6× 1.3k 1.4× 740 0.8× 746 0.9× 137 5.2k
Margaret W. Hilgartner United States 33 1.9k 0.9× 1.1k 1.0× 1.7k 1.8× 1.2k 1.3× 338 0.4× 116 5.5k
A. Gringeri Italy 47 5.1k 2.4× 862 0.7× 863 0.9× 664 0.7× 784 0.9× 175 7.0k
Bruce L. Evatt United States 46 3.7k 1.7× 424 0.4× 578 0.6× 713 0.8× 506 0.6× 150 6.2k
JE Groopman United States 34 1.4k 0.6× 1.6k 1.4× 1.5k 1.5× 755 0.9× 604 0.7× 55 4.5k
C A Ludlam United Kingdom 23 910 0.4× 632 0.5× 231 0.2× 823 0.9× 211 0.2× 54 2.9k
P. B. A. Kernoff United Kingdom 23 1.2k 0.6× 427 0.4× 211 0.2× 506 0.6× 163 0.2× 75 2.3k
Hernán Valdez United States 43 582 0.3× 2.3k 2.0× 2.5k 2.5× 1.4k 1.5× 341 0.4× 154 7.1k
Karina Yazdanbakhsh United States 32 2.1k 1.0× 900 0.8× 1.4k 1.4× 348 0.4× 722 0.8× 111 4.4k
Jeffrey Laurence United States 40 385 0.2× 995 0.9× 1.6k 1.7× 935 1.1× 678 0.8× 130 5.4k

Countries citing papers authored by C. R. Rizza

Since Specialization
Citations

This map shows the geographic impact of C. R. Rizza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. R. Rizza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. R. Rizza more than expected).

Fields of papers citing papers by C. R. Rizza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. R. Rizza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. R. Rizza. The network helps show where C. R. Rizza may publish in the future.

Co-authorship network of co-authors of C. R. Rizza

This figure shows the co-authorship network connecting the top 25 collaborators of C. R. Rizza. A scholar is included among the top collaborators of C. R. Rizza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. R. Rizza. C. R. Rizza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rizza, C. R., Rosemary J. D. Spooner, & Paul Giangrande. (2001). Treatment of haemophilia in the United Kingdom 1981–1996. Haemophilia. 7(4). 349–359. 26 indexed citations
2.
Darby, Sarah C., et al.. (1995). Mortality before and after HIV infection in the complete UK population of haemophiliacs. Nature. 377(6544). 79–82. 87 indexed citations
3.
Hallam, N., et al.. (1993). Low risk of sexual transmission of hepatitis C virus. Journal of Medical Virology. 40(3). 251–253. 62 indexed citations
4.
Rowland-Jones, S L, Rodney E. Phillips, Douglas F. Nixon, et al.. (1992). Human Immunodeficiency Virus Variants That Escape Cytotoxic T-Cell Recognition. AIDS Research and Human Retroviruses. 8(8). 1353–1354. 15 indexed citations
5.
Catalán, José, Ivana Klimeš, Alison Bond, et al.. (1992). The psychosocial impact of HIV infection in men with haemophilia: Controlled investigation and factors associated with psychiatric morbidity. Journal of Psychosomatic Research. 36(5). 409–416. 54 indexed citations
6.
Naylor, J.A., et al.. (1992). Factor VIII gene explains all cases of haemophilia A. The Lancet. 340(8827). 1066–1067. 58 indexed citations
7.
Darby, Stephen E., Richard Doll, Bharat Thakrar, C. R. Rizza, & David Cox. (1990). Time from infection with HIV to onset of AIDS in patients with haemophilia in the UK. Statistics in Medicine. 9(6). 681–689. 29 indexed citations
9.
Darby, Stephen E., et al.. (1989). Seropositivity for HIV in U.K. haemophiliacs. Philosophical transactions of the Royal Society of London. Series B, Biological sciences. 325(1226). 179–183. 8 indexed citations
10.
Nixon, Douglas F., Alain Townsend, John Elvin, et al.. (1988). HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature. 336(6198). 484–487. 381 indexed citations
11.
Rizza, C. R., et al.. (1986). Estimation of genetic risks of carriership for possible carriers of christmas disease (hemophilia b). Revista brasileira de genetica. 9(1). 87–99. 9 indexed citations
13.
Trowell, J, et al.. (1983). Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients.. BMJ. 287(6407). 1754–1757. 163 indexed citations
14.
Forbes, C.D., et al.. (1980). Improving prospects for employment of the haemophiliac.. BMJ. 280(6224). 1169–1172. 8 indexed citations
15.
Rizza, C. R.. (1977). CLINICAL MANAGEMENT OF HAEMOPHILIA. British Medical Bulletin. 33(3). 225–230. 11 indexed citations
16.
Kirkwood, Thomas B. L., et al.. (1977). Identification of Sources of Inter-Laboratory Variation in Factor VIII Assay. Thrombosis and Haemostasis.
17.
Gibson, Benjamin, et al.. (1976). Late sucessful treatment of splenic rupture in a haemophilic boy.. BMJ. 1(6004). 260–262. 5 indexed citations
18.
Gazzard, B G, et al.. (1974). Coagulation factor concentrate in the treatment of the haemorrhagic diathesis of fulminant hepatic failure. Gut. 15(12). 993–998. 29 indexed citations
19.
Rizza, C. R., et al.. (1974). Factor VIII-related antigen in tissues detected by the indirect immunofluorescence technique. Annals of Hematology. 29(4). 241–250. 10 indexed citations
20.
Rizza, C. R.. (1966). Management of haemophilia.. BMJ. 2(5530). 1608–1608. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026